Press Releases

    Print Page  Close Window
BIOMED REALTY INVESTS IN THE CONSTRUCTION OF LABORATORY AND OFFICE FACILITIES AT THE BABRAHAM RESEARCH CAMPUS, CAMBRIDGE, U.K.

SAN DIEGO, April 19, 2017 /PRNewswire/ -- Today, the Biotechnology and Biological Sciences Research Council (BBSRC), Babraham Bioscience Technologies Ltd (BBT) and BioMed Realty, a Blackstone portfolio company, have announced a partnership that will see BioMed Realty signing a long-term lease on approximately eight acres of BBSRC-owned land at the Babraham Research Campus, Cambridge, U.K. The investment will enable the ground-up construction of two new buildings for growing bioscience-based companies at the campus.

The Babraham Research Campus is a leading hub of bioscience research and innovation that supports early stage and growing biomedical enterprises. At the centre of the Campus is the world-class Babraham Institute, which receives strategic funding from BBSRC, and BBT, its trading subsidiary, through which the campus is being managed and further developed.

BioMed Realty Invests in the Construction of Laboratory and Office Facilities at the Babraham Research Campus, Cambridge, UK

Derek Jones, BBT Chief Executive, said, "Over the years, we have had a very good relationship with BioMed Realty at Granta Park, recognising the potential synergies between the two sites.  This is a natural extension of that relationship.  This inward investment in buildings on the site will support those growing scale-up companies who wish to be part of our campus community but are seeking larger premises than we are currently able to provide.  We are excited by the opportunities this brings to continue to grow and develop the campus, and to support the world-leading life science businesses in the Cambridge region."

BioMed Realty, a leading provider of real estate solutions to the life science industry, owns and operates an existing presence in Cambridge at its Granta Park campus. The company plans to invest approximately £35 million to construct two buildings comprising up to approximately 108,000 square feet of integrated laboratory and office facilities. The buildings will host life science companies requiring grow-on space and take advantage of the distinct environment and community at the campus.  After construction, which is anticipated to begin by the end of 2017 and be completed in the second quarter of 2019, it is expected that BBT will manage the property on behalf of BioMed Realty.

"We are very excited about our partnership with BBSRC and the BBT to expand the Babraham Research Campus and our presence in the world-renowned Cambridge, U.K., life science market," said Tim Schoen, CEO and President of BioMed Realty. "Our commitment to Cambridge was forged in 2012 at Granta Park, which we have since enlarged by 250,000 square feet. We pledge to assemble the strongest, most knowledgeable team in the industry to deliver exceptional, state-of-the-art research facilities to foster the ground-breaking science happening at the Babraham Research Campus."

About BioMed Realty

BioMed Realty invests in the highest quality institutional real estate to meet the needs of the growing demand across the life science industry. The company owns or has interests in properties comprising approximately 12 million rentable square feet. Additional information is available at www.biomedrealty.com. Follow us on Twitter @biomedrealty.

About: Babraham Bioscience Technologies and the Babraham Research Campus.

The Babraham Research Campus is a freehold estate of the BBSRC, housing more than 60 biomedical organisations and the Babraham Institute. The aim of the campus is to support U.K. bioscience through academic research, but also with facilities and capabilities for early-stage and growing commercial organisations. The campus is managed and developed by BBT on behalf of the BBT shareholders, BBSRC and the Babraham Institute. www.babraham.co.uk